cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.q3348w
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Tympanuchus phasianellus)",
 "Country is one of (Algeria, Angola, Benin, Botswana, British Indian Ocean Territory, Burkina Faso, Burundi, Cabo Verde, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, Democratic Republic of the, Côte d’Ivoire, Djibouti, Egypt, Equatorial Guinea, Eritrea, Eswatini, Ethiopia, French Southern Territories, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mayotte, Morocco, Mozambique, Namibia, Niger, Nigeria, Réunion, Rwanda, Saint Helena, Ascension and Tristan da Cunha, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tanzania, United Republic of, Togo, Tunisia, Uganda, Western Sahara, Zambia, Zimbabwe)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022953-250711103210423/datasets/export for details.
DOI: 10.15468/dl.pat6ny
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Tympanuchus phasianellus)",
 "Country is one of (American Samoa, Australia, Christmas Island, Cocos (Keeling) Islands, Cook Islands, Fiji, French Polynesia, Guam, Heard Island and McDonald Islands, Kiribati, Marshall Islands, Micronesia (Federated States of), Nauru, New Caledonia, New Zealand, Niue, Norfolk Island, Northern Mariana Islands, Palau, Papua New Guinea, Pitcairn, Samoa, Solomon Islands, Tokelau, Tonga, Tuvalu, United States Minor Outlying Islands, Vanuatu, Wallis and Futuna)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022954-250711103210423/datasets/export for details.
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000596.1
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000470
title: mass spectrometry (MS) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for mass spectrometry (MS)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000596
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n.1
title: (1E,1'E)-1,1'-(3,6-di-tert-butyl-9H-carbazole-1,8-diyl)bis(N-mesitylmethanimine)
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367].
 The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]:
 InChI descriptor[cheminf_000113]: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+, and canonical SMILES descriptor[cheminf_000007]: Cc1cc(C)c(c(c1)C)/N=C/c1cc(cc2c1[nH]c1c2cc(cc1/C=N/c1c(C)cc(cc1C)C)C(C)(C)C)C(C)(C)C, and by the IUPAC name[cheminf_000107]: .
 
 The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]:
 
 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-51915

 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]:
 Melting point descriptor[CHEMINF_000256]: 205.0 - 230.0 (°C)
 Boiling point descriptor[CHEMINF_000257]: 
 Refractive index descriptor[CHEMINF_000253]:

 The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]:
 
 CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 CHMO:0000604 | heteronuclear single quantum coherence (HSQC)
 
 CHMO:0000599 | correlation spectroscopy (COSY)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000601 | heteronuclear multiple bond coherence (HMBC)
 
 CHMO:0000470 | mass spectrometry (MS)
 
 CHMO:0000630 | infrared absorption spectroscopy (IR)
 
 The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: 

 Used ontologies:
 CHEBI - Chemical Entities of Biological Interest
 CHEMINF - chemical information ontology (information entities about chemical entities)
 CHMO - Chemical Methods Ontology
 OBI - Ontology for Biomedical Investigations
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000601
title: heteronuclear multiple bond coherence (HMBC) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for heteronuclear multiple bond coherence (HMBC)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000599
title: correlation spectroscopy (COSY) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for correlation spectroscopy (COSY)
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000604
title: heteronuclear single quantum coherence (HSQC) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for heteronuclear single quantum coherence (HSQC)
DOI: 10.15468/dl.kq4pxz
title: Occurrence Download

description: A dataset containing 19 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Matthiola farinosa"
 ]
}

 The dataset includes 19 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022955-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.14272/ghgfcemmuladqx-ifqufvrcsa-n/chmo0000630
title: infrared absorption spectroscopy (IR) ()
title: InChI=1S/C40H47N3/c1-23-13-25(3)35(26(4)14-23)41-21-29-17-31(39(7,8)9)19-33-34-20-32(40(10,11)12)18-30(38(34)43-37(29)33)22-42-36-27(5)15-24(2)16-28(36)6/h13-22,43H,1-12H3/b41-21+,42-22+

description: dataset for infrared absorption spectroscopy (IR)
DOI: 10.15468/dl.yp22pt
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Pteropus chrysoproctus"
 ]
}

 The dataset includes 4 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022959-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.yjh2mz
title: Occurrence Download

description: A dataset containing 4922 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Notolepis coatsi"
 ]
}

 The dataset includes 4922 records from 42 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022957-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.15968997
title: TGA activation energy Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.

description: Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.
DOI: 10.5281/zenodo.15968998
title: TGA activation energy Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.

description: Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.
DOI: 10.5281/zenodo.15968999
title: TGA Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.

description: Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.
DOI: 10.5281/zenodo.15969000
title: TGA Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.

description: Data from the results published in Papadopoulou, K., Tarani, E., Ainali, N. M., Chrissafis, K., Wurzer, C., Mašek, O., & Bikiaris, D. N. (2023). The effect of biochar addition on thermal stability and decomposition mechanism of poly (butylene succinate) bionanocomposites. Molecules, 28(14), 5330.
DOI: 10.15468/dl.3ktm2s
title: Occurrence Download

description: A dataset containing 67 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Limnocharis flava",
 "Country is Australia",
 "HasCoordinate is true"
 ]
}

 The dataset includes 67 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022960-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2ddxyb
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Erysimum baytopiae"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022961-250711103210423/datasets/export for details.
DOI: 10.15468/dl.mynmgq
title: Occurrence Download

description: A dataset containing 90435 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Myanmar",
 "TaxonKey is Plantae"
 ]
}

 The dataset includes 90435 records from 226 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022888-250711103210423/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.27619932
title: Supplementary Material: Fugitive Acromegaly: A Historical, Clinical, and Translational Perspective

description:  The term ‘fugitive acromegaly’ was introduced by the neurosurgeons Bailey and Cushing in 1928 to describe subjects manifesting signs and symptoms of somatotroph hyperfunction with pituitary insufficiency. Currently, it identifies patients with subtle acromegalic dysmorphisms and inconsistent hormonal profile, possibly presenting only with hyperprolactinemia and related clinical symptoms. Patients have rapidly growing, locally invasive, relapsing pituitary macrotumors that can be classified as either acidophil stem cell tumors (ASCTs) or sparsely granulated somatotroph tumors (SGSTs), both of PIT1-lineage. ASCTs also express estrogen receptor (ER)α, show predominant prolactin (PRL) release, and less abundantly, growth hormone (GH). In contrast, SGSTs have moderately increased GH and IGF1 levels, but rarely PRL increase. ASCTs often present resistance to dopamine agonists, and long-acting somatostatin analogs are used. In contrast, SGSTs are often resistant to somatostatin analogues and instead are treated with the GH receptor antagonist pegvisomant. Differential diagnosis includes mammosomatotroph, mixed GH-/PRL-secreting, immature PIT1-lineage, and densely granulated somatotroph tumors. Studies in ER-sensitive rat tumoral mammosomatotroph cells (GH3, GH4C1) suggest that overexpression of chaperones in immature PIT1-/ER-expressing progenitors induces posttranscriptional conformational changes to tumor suppressors of the ERα and aryl hydrocarbon receptor pathways, like AIP, leading to the development of aggressive pituitary tumors like those causing fugitive acromegaly.
DOI: 10.6084/m9.figshare.27619932.v1
title: Supplementary Material: Fugitive Acromegaly: A Historical, Clinical, and Translational Perspective

description:  The term ‘fugitive acromegaly’ was introduced by the neurosurgeons Bailey and Cushing in 1928 to describe subjects manifesting signs and symptoms of somatotroph hyperfunction with pituitary insufficiency. Currently, it identifies patients with subtle acromegalic dysmorphisms and inconsistent hormonal profile, possibly presenting only with hyperprolactinemia and related clinical symptoms. Patients have rapidly growing, locally invasive, relapsing pituitary macrotumors that can be classified as either acidophil stem cell tumors (ASCTs) or sparsely granulated somatotroph tumors (SGSTs), both of PIT1-lineage. ASCTs also express estrogen receptor (ER)α, show predominant prolactin (PRL) release, and less abundantly, growth hormone (GH). In contrast, SGSTs have moderately increased GH and IGF1 levels, but rarely PRL increase. ASCTs often present resistance to dopamine agonists, and long-acting somatostatin analogs are used. In contrast, SGSTs are often resistant to somatostatin analogues and instead are treated with the GH receptor antagonist pegvisomant. Differential diagnosis includes mammosomatotroph, mixed GH-/PRL-secreting, immature PIT1-lineage, and densely granulated somatotroph tumors. Studies in ER-sensitive rat tumoral mammosomatotroph cells (GH3, GH4C1) suggest that overexpression of chaperones in immature PIT1-/ER-expressing progenitors induces posttranscriptional conformational changes to tumor suppressors of the ERα and aryl hydrocarbon receptor pathways, like AIP, leading to the development of aggressive pituitary tumors like those causing fugitive acromegaly.
DOI: 10.6084/m9.figshare.27619932.v2
title: Supplementary Material: Fugitive Acromegaly: A Historical, Clinical, and Translational Perspective

description:  The term ‘fugitive acromegaly’ was introduced by the neurosurgeons Bailey and Cushing in 1928 to describe subjects manifesting signs and symptoms of somatotroph hyperfunction with pituitary insufficiency. Currently, it identifies patients with subtle acromegalic dysmorphisms and inconsistent hormonal profile, possibly presenting only with hyperprolactinemia and related clinical symptoms. Patients have rapidly growing, locally invasive, relapsing pituitary macrotumors that can be classified as either acidophil stem cell tumors (ASCTs) or sparsely granulated somatotroph tumors (SGSTs), both of PIT1-lineage. ASCTs also express estrogen receptor (ER)α, show predominant prolactin (PRL) release, and less abundantly, growth hormone (GH). In contrast, SGSTs have moderately increased GH and IGF1 levels, but rarely PRL increase. ASCTs often present resistance to dopamine agonists, and long-acting somatostatin analogs are used. In contrast, SGSTs are often resistant to somatostatin analogues and instead are treated with the GH receptor antagonist pegvisomant. Differential diagnosis includes mammosomatotroph, mixed GH-/PRL-secreting, immature PIT1-lineage, and densely granulated somatotroph tumors. Studies in ER-sensitive rat tumoral mammosomatotroph cells (GH3, GH4C1) suggest that overexpression of chaperones in immature PIT1-/ER-expressing progenitors induces posttranscriptional conformational changes to tumor suppressors of the ERα and aryl hydrocarbon receptor pathways, like AIP, leading to the development of aggressive pituitary tumors like those causing fugitive acromegaly.
DOI: 10.6084/m9.figshare.29581280
title: Supplementary Material for: Diverse Metabolic Control of Phosphoglucomutases by Bisphosphorylated Sugars in Heterotrophic Bacteria

description: Introduction: Phosphoglucomutases (PGM) are crucial for bacterial fitness, environmental survival, pathogenicity, and cell envelope stability, making them potential new targets for combating bacterial infection and transmission. PGM functionality relies on initial phosphorylation by the activator glucose-1,6-bisphosphate (glucose-1,6-BP). While the origin of glucose-1,6-BP in vertebrates is well investigated, a bacterial glucose-1,6-BP synthase was only recently identified in the cyanobacterium Synechocystis. In this photoautotroph, a secondary PGM (SynPGM2) efficiently catalyzes glucose-1,6-BP synthesis from fructose-1,6-bisphosphate (fructose-1,6-BP) and glucose-1-phosphate or glucose-6-phosphate . A homologous PGM from the heterotrophic Bacteroides salyersiae, belonging to the same conserved domain subfamily (cd05800) as SynPGM2, exhibited similar activity, suggesting that bacterial glucose-1,6-BP synthesis is a feature of this specific subfamily. Methods: To investigate the specificity and regulation of various PGM enzymes from different heterotrophic bacteria, recombinant enzymes were purified and analyzed using enzymatic assays and HPLC-MS. Results: We demonstrate that glucose-1,6-BP synthesis extends beyond the cd5800 subfamily to the cd05801, cd05799, and cd03089 subfamilies. PGMs from Escherichia coli (cd05801 and cd03089), Enterococcus faecium (cd05799), Yersinia enterocolitica (cd05801), and Candidatus Gastranaerophilales (cd05800) catalyze the same fructose-1,6-BP-dependent synthesis reaction of glucose-1,6-BP as SynPGM2. Notably, fructose-1,6-BP, a known inhibitor of some PGM, does not inhibit these bacterial PGMs. Moreover, E. faecium PGM, belonging to the same subfamily as the mammalian glucose 1,6 BP synthase, efficiently catalyzes the mammalian-type 1,3-bisphosphoglycerate-dependent glucose 1,6-BP synthesis reaction. Conclusion: All investigated heterotrophic bacteria appear to use their primary PGM for both PGM activity and activator synthesis, suggesting a more versatile and less specialized role for PGMs in heterotrophic bacteria.
DOI: 10.6084/m9.figshare.29581280.v1
title: Supplementary Material for: Diverse Metabolic Control of Phosphoglucomutases by Bisphosphorylated Sugars in Heterotrophic Bacteria

description: Introduction: Phosphoglucomutases (PGM) are crucial for bacterial fitness, environmental survival, pathogenicity, and cell envelope stability, making them potential new targets for combating bacterial infection and transmission. PGM functionality relies on initial phosphorylation by the activator glucose-1,6-bisphosphate (glucose-1,6-BP). While the origin of glucose-1,6-BP in vertebrates is well investigated, a bacterial glucose-1,6-BP synthase was only recently identified in the cyanobacterium Synechocystis. In this photoautotroph, a secondary PGM (SynPGM2) efficiently catalyzes glucose-1,6-BP synthesis from fructose-1,6-bisphosphate (fructose-1,6-BP) and glucose-1-phosphate or glucose-6-phosphate . A homologous PGM from the heterotrophic Bacteroides salyersiae, belonging to the same conserved domain subfamily (cd05800) as SynPGM2, exhibited similar activity, suggesting that bacterial glucose-1,6-BP synthesis is a feature of this specific subfamily. Methods: To investigate the specificity and regulation of various PGM enzymes from different heterotrophic bacteria, recombinant enzymes were purified and analyzed using enzymatic assays and HPLC-MS. Results: We demonstrate that glucose-1,6-BP synthesis extends beyond the cd5800 subfamily to the cd05801, cd05799, and cd03089 subfamilies. PGMs from Escherichia coli (cd05801 and cd03089), Enterococcus faecium (cd05799), Yersinia enterocolitica (cd05801), and Candidatus Gastranaerophilales (cd05800) catalyze the same fructose-1,6-BP-dependent synthesis reaction of glucose-1,6-BP as SynPGM2. Notably, fructose-1,6-BP, a known inhibitor of some PGM, does not inhibit these bacterial PGMs. Moreover, E. faecium PGM, belonging to the same subfamily as the mammalian glucose 1,6 BP synthase, efficiently catalyzes the mammalian-type 1,3-bisphosphoglycerate-dependent glucose 1,6-BP synthesis reaction. Conclusion: All investigated heterotrophic bacteria appear to use their primary PGM for both PGM activity and activator synthesis, suggesting a more versatile and less specialized role for PGMs in heterotrophic bacteria.